Foresite Capital is a venture capital firm which invests in companies in the healthcare industry. Dr. Jim Tananbaum, who is the Founder, Managing Director, and Chief Executive Officer of the firm, announced that he was adding Dr. Molly He as a Venture Partner at the company. Dr. He has over 15 years experience in biotechnology, genomic r&d. Prior to joining Foresite Capital, she was the Senior Director at Illumina.
When making the announcement, Dr. Tananbaum said that Dr. He is well known in the scientific research community who has vast experience in next-generation sequencing. He said that she is a leader in the industry who will be a great asset on his team. Dr. He performed research at Illumina that involved global protein reagent innovations. She has also worked at Pacific Biosciences where was engaged in their research and development of singular molecular real-time sequencing chemistry. During her career she has also worked on structural-based antibody design that was designed to provide drug therapies for cancer and immune diseases. She has published over 20 research papers and holds over 20 patent applications.
Dr. Jim Tananbaum founded San Francisco-based Foresite Capital in 2010. He specializes investing in healthcare companies that have market disruptive drugs in development that have products in late-stage clinical trials. This includes pharmaceutical companies, diagnostics, medical devices, services, and genomics. According to Businesswire, he earned his medical degree at Harvard Medical School in 1989 and a Master of Science degree in the same year from the Massachusetts Institute of Technology. In 1991 he earned his MBA at Harvard Business School.
As per drewaltizer, it was in 1991 that Dr. Tananbaum founded his first company, GelTex. He served as CEO of the company until is acquired by Genzyme for $1.6 billion. He served as a Partner at Sierra Ventures for four years, another venture capitalist firm that specialized in the healthcare industry. He has also co-founded Theravance Biopharma whose mission is to created medicines that help people with serious illnesses. Dr. Jim Tananbaum also co-founded Prospect Venture Partners where he worked at the Managing Director for nine years, from 2001 to 2010. Sourced info: Insidermonkey.com